Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice
Authors:
- Liane B RussellLRLiane B Russell
- Patricia R HunsickerPHPatricia R Hunsicker
- Adelle M HackAHAdelle M Hack
- Terry AshleyTATerry Ashley
- 1 January 2000
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 464 (2) , 201-212
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Unlike other chemicals, etoposide (a topoisomerase-II inhibitor) produces peak mutagenicity in primary spermatocytes of the mouseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- Evidence for Cyclophosphamide-Induced Gene Conversion and Mutation in Mouse Germ CellsToxicology and Applied Pharmacology, 1997
- Cisplatin increases meiotic crossing-over in miceProceedings of the National Academy of Sciences, 1997
- A Super New Twist on the Initiation of Meiotic RecombinationCell, 1997
- Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposideMutagenesis, 1996
- Aneuploidy in germ cells: Etiologies and risk factorsEnvironmental and Molecular Mutagenesis, 1996
- Human aneuploidy: Incidence, origin, and etiologyEnvironmental and Molecular Mutagenesis, 1996
- Meiotic recombination and germ cell aneuploidyEnvironmental and Molecular Mutagenesis, 1996
- Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposideTeratogenesis, Carcinogenesis, and Mutagenesis, 1994
- Colcemid effects on homologue pairing and crossing over during fetal mouse oogenesisCellular and Molecular Life Sciences, 1989